Stock 4584 KIDSWELL BIO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Kidswell Bio Corporation

Equities

4584

JP3386460004

Delayed Japan Exchange
Other stock markets
 05:02:26 17/07/2024 BST 		5-day change 1st Jan Change
148 JPY +3.50% Intraday chart for Kidswell Bio Corporation +10.45% +10.45%
2023 Kidswell Bio Corporation announced that it has received ¥22.8 million in funding from CVI Investments, Inc. CI
2023 Kidswell Bio Corporation announced that it expects to receive ¥22.8 million in funding from CVI Investments, Inc. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chiome Bioscience, Kidswell Bio to Collaborate on Development of Cancer Antibody
MT
Kidswell Bio Corporation Reports Earnings Results for the Half Year Ended September 30, 2021
CI
Gene Techno Science Co.,Ltd. Reports Earnings Results for the Year Ended March 2020
CI
Dojin Group Co., Ltd. entered into a share transfer agreement to acquire Advanced Cell Technology and Engineering Ltd. from Gene Techno Science Co.,Ltd. for ¥0.
CI
Gene Techno Science Enters into Research Agreement with Nagoya University
CI
Gene Techno Science Co., Ltd Has Executes A Joint Research Agreement with Oita University
CI
Gene Techno Science Co.,Ltd. acquired remaining 94.7% stake in Japan Regenerative Medicine Co., Ltd. from Noritsu Koki Co., Ltd. for ¥0.
CI
Gene Techno Science Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020
CI
Gene Techno Science Co.,Ltd. Announces Earnings Results for the Six Months Ended September 30, 2019
CI
Gene Techno Science Co., Ltd. and Sanwa Kagaku Kenkyusho Co., Ltd. Announces Manufacturing and Marketing Approval for Darbepoetin Alpha Biosimilars in Japan
CI
Gene Techno Science Co.,Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
Gene Techno Science Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2019
CI
NanoCarrier Co., Ltd. cancelled the acquisition of 5.23% stake in Gene Techno Science Co.,Ltd. from Noritsu Koki Bio Holdings LLC.
CI
Gene Techno Science Co.,Ltd. completed the acquisition of Advanced Cell Technology and Engineering Ltd from Koichi Otomo, Yoshihiko Kitajima, Akira Katayama, Taro Koike, Namiko Shinohara and others.
CI
Gene Techno Science Co.,Ltd. signed a share exchange agreement to acquire Advanced Cell Technology and Engineering Ltd from Koichi Otomo, Yoshihiko Kitajima, Akira Katayama, Taro Koike, Namiko Shinohara and others for ¥5.7 billion.
CI
Gene Techno Science Co.,Ltd. Announces Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2019
CI
NanoCarrier Co., Ltd. agreed to acquire 5.23% stake in Gene Techno Science Co.,Ltd. from Noritsu Koki Bio Holdings LLC for ¥1.2 billion.
CI
Launchpad12 LLC completed the acquisition of an additional 39.75% stake in Gene Techno Science Co., Ltd. from DyDo DRINCO, INC., Japan Securities Finance Co. Ltd., Asset Management Arm, SBI Holdings Inc., Asset Management Arm, Senju Pharmaceutical Co.,Ltd. and others for ¥5.4 billion.
CI
Launchpad12 LLC offered to acquire remaining 81.99% stake in Gene Techno Science Co., Ltd. from DyDo DRINCO, INC., Japan Securities Finance Co. Ltd., Asset Management Arm, SBI Holdings Inc., Asset Management Arm, Senju Pharmaceutical Co.,Ltd. and others for ¥11.1 billion.
CI
Senju Pharmaceutical Co.,Ltd. completed the acquisition of 5.7% stake in Gene Techno Science Co., Ltd. from Whiz Healthcare PE Series1 LP, a fund of Whiz Partners Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4584 Stock
  4. News Kidswell Bio Corporation
  5. Highlights